首页 | 本学科首页   官方微博 | 高级检索  
检索        

原发性与转移性肝癌病人LAK活性,IL—2水平及sIL—2R表达
引用本文:张方信,邓芝云.原发性与转移性肝癌病人LAK活性,IL—2水平及sIL—2R表达[J].兰州医学院学报,1995,21(1):24-25.
作者姓名:张方信  邓芝云
作者单位:兰州军区总医院消化科 (张方信,梁守德),兰州军区总医院实验科 (邓芝云,于兰),兰州军区总医院实验科(杨霄鹏)
摘    要:作者对26例原发性肝癌(PHC)、28例转移性肝癌(MLC)病人外周血单个核细胞(PBMC)的LAK活性、IL-2水平及sIL-2R表达进行了研究。结果发现,PHC及MLC病人PBMC的LAK活性、IL-2水平下降而sIL-2R表达上升。提示肿瘤病人处于免疫异常状态,检测sIL-2R/IL-2比值,对判断肿瘤病人及转移性肿瘤病人的生物学意义具有重要价值。

关 键 词:原发性肝癌  转移性肝癌  肝癌  自然杀伤细胞

LAK Activity IL-2 and sIL-2R Level in Patients with Primary and Metastasis Liver Carcernoma
Zhang Fangxin,et al.LAK Activity IL-2 and sIL-2R Level in Patients with Primary and Metastasis Liver Carcernoma[J].Journal of Lanzhou Medical College,1995,21(1):24-25.
Authors:Zhang Fangxin  
Abstract:LAK activity, IL -2 and soluble IL -2 recepotor (sIL - 2R) of PBMC were studied in 26 patients with primary hepatic carcinoma (PHC) and in 28 patients with metastasis liver carcinoma (MLC). The LAK ac-tivity and IL - 2 of PHC and MLC patients were significantly lower, sIL - 2R/IL - 2 was remarkably increased than those of normai controls;and IL -2 of MLC patients was significantly lower, sIL -2R and sIL - 2R/IL -2 were remarkably enhanced than those of PHC patients. The results showed that the decreased LAK activity, IL -2 and increased sIL - 2R/IL - 2 by PBMC in the patients rnight refiect the immunologic abnormalities and clinical staging,especially in MLC patients.
Keywords:Primary hepatic cancer  Metastasis Liver cancer  LAK activity  IL- 2  sIL-2R
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号